Mobile App

Google Play Apple Store
Clinical Controversies in the Management of HLH/MAS
AMA/ANCC Activity - Lecture Library Slide Set
Clinical Viewpoints HLH/MAS includes a curriculum that highlights the very latest clinical data in hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Slides are developed and updated throughout the year by leading HLH/MAS expert physicians. All content is reviewed and approved by the Clinical Viewpoints HLH/MAS Planning Committee.

The current initial treatment for hemophagocytic lymphohistiocytosis (HLH) and/or macrophage activation syndrome (MAS) aims to suppress the excessive activation of the immune system and treat the cytokine storm. However, contemporary HLH and MAS management is an evolving science that builds off each advance in basic/clinical research and clinical experience. This case-based slide kit discusses current controversies in the management of secondary HLH, including MAS.
Review the activity and claim AMA or ANCC credit/contact hour after completion of a brief pretest and posttest/evaluation.



Alexei Grom, MDP Alexei Grom, MD
Professor of Pediatrics
Research Director
Division of Rheumatology
Cincinnati Children’s Hospital Medical Center
Cincinnati, Ohio

Clinical Viewpoints HLH/MAS includes a curriculum that highlights the very latest clinical data in hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Slides are developed and updated throughout the year by leading HLH/MAS expert physicians. All content is reviewed and approved by the Clinical Viewpoints HLH/MAS Planning Committee.

The current initial treatment for hemophagocytic lymphohistiocytosis (HLH) and/or macrophage activation syndrome (MAS) aims to suppress the excessive activation of the immune system and treat the cytokine storm. However, contemporary HLH and MAS management is an evolving science that builds off each advance in basic/clinical research and clinical experience. This case-based slide kit discusses current controversies in the management of secondary HLH, including MAS.
Review the activity and claim AMA or ANCC credit/contact hour after completion of a brief pretest and posttest/evaluation.





Alexei Grom, MDP Alexei Grom, MD
Professor of Pediatrics
Research Director
Division of Rheumatology
Cincinnati Children’s Hospital Medical Center
Cincinnati, Ohio

 

Thank you for completing this activity!


An email will be sent to you shortly with your certificate attached. If you do not receive this email within 30 minutes, please check your "Junk" or "Spam" folder. You can also visit your profile page for a list of downloadable certificates you've earned.

For your convenience you can download your certificate by clicking the button below.


If you have any questions or experience issues, please contact us.

20
Supported by an independent educational grant from Sobi, Inc.

Launch Date: September 6, 2023
Release Date: September 6, 2023
Expiration Date: August 30, 2024

August 30, 2024
Mini Module
7623
HLH-MAS.LectureLibrary23_WebBanner(1150).png
False
  • Hematology
  • Rheumatology
  • Rare Diseases
  • Archives
Hematology

CookieConsent

Change Settings